Iovance Biotherapeutics, Inc. SEC filings IOVA

Iovance Biotherapeutics, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Oct 1, 2010. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.

Iovance Biotherapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Other events
Oct 29, 2026 Oct 29, 2026
8-K Current report
Other events
Oct 5, 2026 Oct 5, 2026
8-K Current report
Other events
Sep 29, 2026 Sep 29, 2026
8-K Current report
Other events
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Other events
Jul 2, 2026 Jun 30, 2026
S-8 Employee stock plan registration Jun 18, 2026 —
S-8 Employee stock plan registration Jun 18, 2026 —
S-3ASR Automatic shelf registration Jun 18, 2026 —
8-K Current report
Shareholder vote results, Other events
Jun 10, 2026 Jun 4, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
ARS Annual report to shareholders May 1, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 10, 2026
PRE 14A Preliminary proxy statement Apr 17, 2026 Jun 10, 2026
8-K Current report
Officer or director change
Mar 20, 2026 Mar 17, 2026
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations, Other events
Feb 24, 2026 Feb 24, 2026
8-K Current report
Other events
Jan 9, 2026 Jan 9, 2026
S-8 Employee stock plan registration Nov 12, 2025 —
S-8 Employee stock plan registration Nov 12, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Aug 29, 2025 Aug 29, 2025
8-K Current report
Material agreement
Aug 22, 2025 Aug 22, 2025
424B5 Prospectus supplement Aug 22, 2025 —
8-K Current report
Other events
Aug 19, 2025 Aug 18, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change, Other events
Jul 15, 2025 Jul 15, 2025
8-K Current report
Officer or director change
Jul 3, 2025 Jun 30, 2025
8-K Current report
Officer or director change
Jun 13, 2025 Jun 10, 2025
8-K Current report
Shareholder vote results
Jun 10, 2025 Jun 10, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 10, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Other events
Feb 10, 2025 Feb 10, 2025
S-8 Employee stock plan registration Dec 13, 2024 —
8-K Current report
Material agreement, Agreement ended
Nov 21, 2024 Nov 15, 2024
8-K Current report
Other events
Nov 8, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Aug 9, 2024 Aug 8, 2024
S-8 Employee stock plan registration Aug 9, 2024 —
S-8 Employee stock plan registration Aug 9, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Other events
Jun 28, 2024 Jun 28, 2024
8-K Current report
Shareholder vote results
Jun 11, 2024 Jun 11, 2024
8-K Current report
Other events
Jun 3, 2024 May 31, 2024
8-K Current report
Other events
May 24, 2024 May 23, 2024
DEFA14A Additional proxy material May 17, 2024 —
S-8 Employee stock plan registration May 10, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders May 1, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 11, 2024
8-K Current report
Other events
Apr 3, 2024 Apr 3, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change
Mar 29, 2024 Mar 26, 2024
8-K Current report
Other events
Mar 4, 2024 Mar 4, 2024
8-K Current report
Other events
Feb 29, 2024 Feb 28, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
8-K Current report
Other events
Feb 22, 2024 Feb 22, 2024
424B5 Prospectus supplement Feb 21, 2024 —
8-K Current report
Material agreement, Other events
Feb 20, 2024 Feb 20, 2024
8-K Current report
Results of operations, Other events
Feb 20, 2024 Feb 16, 2024
8-K Current report
Other events
Jan 26, 2024 Jan 25, 2024
8-K Current report
Other events
Jan 8, 2024 Jan 8, 2024
8-K Current report
Other events
Dec 27, 2023 Dec 27, 2023
UPLOAD Letter from the SEC Nov 21, 2023 —
CORRESP Letter to the SEC Nov 17, 2023 —
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
UPLOAD Letter from the SEC Oct 26, 2023 —
8-K Current report
Other events
Sep 15, 2023 Sep 15, 2023
8-K Current report
Regulation FD disclosure, Other events
Aug 18, 2023 Aug 16, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Other events
Jul 13, 2023 Jul 13, 2023
424B5 Prospectus supplement Jul 11, 2023 —
8-K Current report
Material agreement, Other events
Jul 11, 2023 Jul 10, 2023
424B5 Prospectus supplement Jul 10, 2023 —
8-K Current report
Results of operations, Other events
Jul 10, 2023 Jul 10, 2023
8-K Current report
Other events
Jul 10, 2023 Jul 10, 2023
8-K Current report
Material agreement, Agreement ended
Jun 16, 2023 Jun 16, 2023
424B5 Prospectus supplement Jun 16, 2023 —
S-3ASR Automatic shelf registration Jun 16, 2023 —
S-8 Employee stock plan registration Jun 12, 2023 —
S-8 Employee stock plan registration Jun 12, 2023 —
8-K Current report
Shareholder vote results
Jun 6, 2023 Jun 6, 2023
8-K/A Amended current report Jun 2, 2023 May 18, 2023
8-K Current report
Other events
May 30, 2023 May 26, 2023
8-K Current report
Acquisition or sale of assets
May 18, 2023 May 18, 2023
S-8 Employee stock plan registration May 10, 2023 —
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 26, 2023 —
DEF 14A Proxy statement Apr 26, 2023 —
UPLOAD Letter from the SEC Apr 25, 2023 —
8-K Current report
Officer or director change
Apr 24, 2023 Apr 18, 2023
PRER14A Filing Apr 19, 2023 —
PRE 14A Preliminary proxy statement Apr 14, 2023 —
8-K Current report
Other events
Mar 27, 2023 Mar 24, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K/A Amended current report Jan 27, 2023 Jan 23, 2023
8-K Current report
Material agreement, Other events
Jan 23, 2023 Jan 23, 2023
8-K Current report
Other events
Jan 11, 2023 Jan 10, 2023
8-K Current report
Material agreement, Agreement ended
Nov 18, 2022 Nov 18, 2022
424B5 Prospectus supplement Nov 18, 2022 —
8-K Current report
Other events
Nov 18, 2022 Nov 18, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Other events
Sep 12, 2022 Sep 12, 2022
8-K Current report
Other events
Aug 29, 2022 Aug 25, 2022
S-8 Employee stock plan registration Aug 4, 2022 —
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 13, 2022 Jun 10, 2022
8-K Current report
Other events
May 26, 2022 May 26, 2022
8-K Current report
Other events
May 13, 2022 May 13, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Bylaw or fiscal year change
Apr 29, 2022 Apr 25, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 10, 2022
8-K Current report
Other events
Apr 5, 2022 Apr 5, 2022
S-8 Employee stock plan registration Mar 11, 2022 —
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Officer or director change
Jan 19, 2022 Jan 12, 2022
8-K Current report
Other events
Jan 10, 2022 Jan 10, 2022
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
S-8 Employee stock plan registration Sep 23, 2021 —
8-K Current report
Officer or director change
Sep 23, 2021 Sep 22, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Other events
Jun 29, 2021 Jun 29, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2021 Jun 11, 2021
8-K Current report
Other events
May 20, 2021 May 18, 2021
8-K Current report
Officer or director change
May 19, 2021 May 18, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Material agreement, Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 11, 2021
8-K Current report
Bylaw or fiscal year change
Apr 26, 2021 Apr 20, 2021
8-K Current report
Other events
Apr 12, 2021 Apr 9, 2021
8-K Current report
Officer or director change, Other events
Mar 15, 2021 Mar 15, 2021
8-K Current report
Auditor change
Mar 12, 2021 Mar 12, 2021
8-K Current report
Officer or director change
Mar 11, 2021 Mar 5, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
424B5 Prospectus supplement Feb 9, 2021 —
8-K Current report
Material agreement
Feb 9, 2021 Feb 8, 2021
8-K Current report
Material agreement
Feb 9, 2021 Feb 8, 2021
8-K Current report
Other events
Jan 7, 2021 Jan 7, 2021
8-K Current report
Officer or director change, Other events
Dec 14, 2020 Dec 14, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Other events
Oct 14, 2020 Oct 14, 2020
8-K Current report
Other events
Oct 5, 2020 Oct 5, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
S-8 Employee stock plan registration Jun 19, 2020 —
S-8 Employee stock plan registration Jun 19, 2020 —
8-K Current report
Officer or director change
Jun 12, 2020 Jun 10, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 9, 2020 Jun 8, 2020
8-K Current report
Other events
Jun 2, 2020 Jun 2, 2020
8-K Current report
Other events
May 29, 2020 May 27, 2020
424B5 Prospectus supplement May 29, 2020 —
424B5 Prospectus supplement May 27, 2020 —
S-3ASR Automatic shelf registration May 27, 2020 —
8-K Current report
Bylaw or fiscal year change, Other events
May 27, 2020 May 27, 2020
8-K Current report
Other events
May 22, 2020 May 22, 2020
8-K Current report
Other events
May 8, 2020 May 8, 2020
10-Q Quarterly report May 5, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 5, 2020 May 5, 2020
DEFA14A Additional proxy material Apr 28, 2020 —
DEF 14A Proxy statement Apr 27, 2020 Jun 8, 2020
10-K Annual report Feb 25, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 25, 2020 Feb 25, 2020
CT ORDER Filing Nov 8, 2019 —
10-Q Quarterly report Nov 4, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 4, 2019 Nov 4, 2019
EFFECT Filing Sep 24, 2019 —
CORRESP Letter to the SEC Sep 20, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IOVA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Carlos, CA
SEC filer status
Accelerated filer
SEC CIK
1425205
Former names
Lion Biotechnologies, Inc. (until Jun 5, 2017); Genesis Biopharma, Inc (until Sep 23, 2013); FREIGHT MANAGEMENT CORP (until Mar 8, 2010)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.